October 22, 2014 8:38 PM ET

Capital Markets

Company Overview of Amgen Ventures

Company Overview

Amgen Ventures is a venture capital investment arm of Amgen Inc. specializing in investments in early and later stage companies. The firm primarily invests in the biotechnology sector with a focus on discovering and developing human therapeutics with a focus on oncology, inflammation, hematology, nephrology, metabolic disorders, neuroscience, and cardiovascular therapeutics. In oncology and hematology it focuses on novel therapeutics including signal transduction, cell cycle, and apoptosis; hematopoiesis including anemia, neutropenia, and stem cell mobilization; and supportive care including mucositis and cachexia. In nephrology the firm focuses on renal failure and hyperparathyroidism. For ...

1120 Veterans Boulevard

South San Francisco

San Francisco, CA 94080

United States

Founded in 2004





Key Executives for Amgen Ventures

Managing Director
Compensation as of Fiscal Year 2014.

Amgen Ventures Key Developments

Amgen Ventures Presents at 14th Annual Biotech in Europe Forum for Global Partnering & Investment, Sep-30-2014 11:00 AM

Amgen Ventures Presents at 14th Annual Biotech in Europe Forum for Global Partnering & Investment, Sep-30-2014 11:00 AM. Venue: Congress Center Basel, MCH Messe Schweiz (Basel) AG, CH-4005 Basel, Switzerland. Speakers: Janis Naeve, Director.

Similar Private Companies By Industry

Company Name Region
Enclave Capital LLC United States
New Capital Advisors United States
ClearRidge Capital, LLC United States
R. D. Smith & Co. United States
CIG Capital Advisors, Inc. United States

Recent Private Companies Transactions

Private Placement
July 10, 2014
NexImmune, Inc.
March 18, 2014
Gamida Cell Ltd.
Private Placement
December 16, 2013
Atara Biotherapeutics, Inc.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Amgen Ventures, please visit www.amgen.com/partners/amgen_ventures.html. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.